1. Hamley, I.W., The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization. Chemical reviews, 2012. 112(10): p. 5147-5192.
2. Murphy, M.P. and H. LeVine III, Alzheimer's disease and the amyloid-β peptide. Journal of Alzheimer's disease, 2010. 19(1): p. 311-323.
3. Ballard, C., et al., Alzheimer's disease. the Lancet, 2011. 377(9770): p. 1019-1031.
4. Jia, L., et al., Highly efficient soluble expression, purification and characterization of recombinant Aβ42 from Escherichia coli. RSC advances, 2018. 8(33): p. 18434-18441.
5. Prakash, P., et al., Rapid, refined, and robust method for expression, purification, and characterization of recombinant human amyloid beta 1-42. Methods and Protocols, 2019. 2(2): p. 48.
6. Tickler, A.K., A.B. Clippingdale, and J.D. Wade, Amyloid-β as a “difficult sequence” in solid phase peptide synthesis. Protein and peptide letters, 2004. 11(4): p. 377-384.
7. Finder, V.H., et al., The recombinant amyloid-β peptide Aβ1–42 aggregates faster and is more neurotoxic than synthetic Aβ1–42. Journal of molecular biology, 2010. 396(1): p. 9-18.
8. Jia, L., et al., Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review. Critical reviews in biotechnology, 2020. 40(4): p. 475-489.
9. Garai, K., et al., Expression and purification of amyloid-beta peptides from Escherichia coli. Protein Expr Purif, 2009. 66(1): p. 107-12.
10. Dahlgren, K.N., et al., Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. Journal of Biological Chemistry, 2002. 277(35): p. 32046-32053.
11. Ying, Z., et al., Preparation and Characterization of a Monoclonal Antibody with High Affinity for Soluble Aβ Oligomers. Hybridoma, 2009. 28(5): p. 349-354.
12. Ryan, D.A., et al., An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies. Journal of neuroscience methods, 2010. 190(2): p. 171-179.
13. Chhetri, G., et al., An improved method for high-level soluble expression and purification of recombinant amyloid-beta peptide for in vitro studies. Protein Expression and Purification, 2015. 114: p. 71-76.
14. Garai, K., et al., Expression and purification of amyloid-β peptides from Escherichia coli. Protein expression and purification, 2009. 66(1): p. 107-112.
15. Stephens, A.D., et al., Fast purification of recombinant monomeric amyloid-β from E. coli and amyloid-β-mCherry aggregates from mammalian cells. ACS Chemical Neuroscience, 2020. 11(20): p. 3204-3213.
16. Walsh, D.M., et al., A facile method for expression and purification of the Alzheimer’s disease‐associated amyloid β‐peptide. The FEBS journal, 2009. 276(5): p. 1266-1281.
17. Caine, J.M., et al., Oligomerization and toxicity of Aβ fusion proteins. Biochemical and biophysical research communications, 2011. 409(3): p. 477-482.
18. Jia, L., et al., Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His6-Tagged Aβ1–42. ACS Chemical Neuroscience, 2018. 10(3): p. 1251-1262.
19. Liao, Y.-H. and Y.-R. Chen, A novel method for expression and purification of authentic amyloid-β with and without 15N labels. Protein expression and purification, 2015. 113: p. 63-71.
20. Long, F., W. Cho, and Y. Ishii, Expression and purification of 15N-and 13C-isotope labeled 40-residue human Alzheimer’s β-amyloid peptide for NMR-based structural analysis. Protein expression and purification, 2011. 79(1): p. 16-24.
21. Gopal, G.J. and A. Kumar, Strategies for the production of recombinant protein in Escherichia coli. The protein journal, 2013. 32: p. 419-425.
22. Vosough, F. and A. Barth, Characterization of homogeneous and heterogeneous amyloid-β42 oligomer preparations with biochemical methods and infrared spectroscopy reveals a correlation between infrared spectrum and oligomer size. ACS Chemical Neuroscience, 2021. 12(3): p. 473-488.
23. Pujol-Pina, R., et al., SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer s disease: appealing for ESI-IM-MS. Scientific reports, 2015. 5(1): p. 14809.
24. Kim, E.-K., et al., Large-scale production of soluble recombinant amyloid-β peptide 1–42 using cold-inducible expression system. Protein expression and purification, 2012. 86(1): p. 53-57.
25. Hiroaki, H., Molecular mechanisms of amyloid-β peptide fibril and oligomer formation: NMR-based challenges. Biophysics and Physicobiology, 2023. 20(1).
26. Stine, W.B., et al., Preparing synthetic Aβ in different aggregation states. Methods Mol Biol, 2011. 670: p. 13-32.
27. Shobo, A., et al., Biophysical characterization as a tool to predict amyloidogenic and toxic properties of amyloid‐β42 peptides. FEBS letters, 2022. 596(11): p. 1401-1411.
28. Zhang, H., et al., Cellular response to β-amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics. Animal Model Exp Med, 2023. 6(1): p. 3-9.
29. Leong, Y.Q., et al., Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metab Brain Dis, 2020. 35(1): p. 11-30.
30. Kronqvist, N., et al., Efficient protein production inspired by how spiders make silk. Nature communications, 2017. 8(1): p. 15504.
31. Satakarni, M. and R. Curtis, Production of recombinant peptides as fusions with SUMO. Protein expression and purification, 2011. 78(2): p. 113-119.